指南与共识冠心病心力衰竭与心肌病心律失常

斋月禁食:心血管疾病患者的建议

Ramadan fasting: recommendations for patients with cardiovascular disease.
指南 / 共识 · Heart · 2021-05-14

斋月禁食为全球多数穆斯林所遵守,持续一个月,从黎明到日落禁食禁饮。针对心血管疾病患者的斋月禁食安全性研究稀少、多为观察性、样本量小且随访短。该文通过专家共识和公认框架对患者进行风险分层:低/中危(如稳定型心绞痛或非重度心衰)可在药物和临床状况允许下禁食;高危(如心律失常控制不佳或近期心肌梗死)和极高危(如晚期心衰)不应禁食,可考虑非连续禁食或缩短禁食日等安全替代方案。

要点

  • 低/中危心血管患者(如稳定型心绞痛、非重度心衰)在药物和临床状况允许下可禁食。
  • 高危(如心律失常控制不佳、近期心梗)和极高危(如晚期心衰)患者不应禁食,可考虑安全替代方案。
  • 禁食患者应在斋月前接受风险和管理教育,斋月后重新评估风险状态和病情。

核心结论

  • 低/中危心血管疾病患者可在药物和临床状况允许下进行斋月禁食,高危和极高危患者不应禁食并应考虑安全替代方案。
  • 所有禁食患者应在斋月前接受风险和管理教育,并在斋月后重新评估风险状态和病情。

研究设计与样本

  • 该文为综述,检索文献以帮助医疗专业人员教育、讨论和管理考虑禁食的心血管疾病患者。
  • 关于心脏病患者斋月禁食安全性的研究稀少、为观察性、样本量小且随访短。

主要发现

  • 使用专家共识和公认框架将患者风险分层为低或中危、高危和极高危。
  • 低或中危示例包括稳定型心绞痛或非重度心衰;高危示例包括心律失常控制不佳或近期心肌梗死;极高危示例包括晚期心衰。

关键数值与推荐

  • 低/中危组可在药物和临床状况允许下禁食。
  • 高危或极高危组不应禁食,可考虑非连续禁食或缩短禁食日(如冬季)等安全替代方案。
  • 所有禁食患者应在斋月前接受风险和管理教育,包括脱水、液体超负荷和不适时终止禁食的风险。
  • 所有禁食患者应在斋月后复查以重新评估风险状态和病情。

临床怎么用

  • 对考虑斋月禁食的心血管疾病患者进行风险分层,低/中危者在药物和临床状况允许下可禁食。
  • 高危和极高危患者建议不禁食,并讨论非连续禁食或缩短禁食日等安全替代方案。
  • 斋月前对禁食患者进行风险和管理教育,斋月后重新评估风险状态和病情。

局限性

  • 关于心脏病患者斋月禁食安全性的研究稀少、为观察性、样本量小且随访短。
  • 需要进一步研究阐明禁食对不同心血管疾病患者心血管系统的获益和风险,以完善这些建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ramadan fasting is observed by most of the 1.8 billion Muslims around the world. It lasts for 1 month per the lunar calendar year and is the abstention from any food and drink from dawn to sunset. While recommendations on 'safe' fasting exist for patients with some chronic conditions, such as diabetes mellitus, guidance for patients with cardiovascular disease is lacking. We reviewed the literature to help healthcare professionals educate, discuss and manage patients with cardiovascular conditions, who are considering fasting. Studies on the safety of Ramadan fasting in patients with cardiac disease are sparse, observational, of small sample size and have short follow-up. Using expert consensus and a recognised framework, we risk stratified patients into 'low or moderate risk', for example, stable angina or non-severe heart failure; 'high risk', for example, poorly controlled arrhythmias or recent myocardial infarction; and 'very high risk', for example, advanced heart failure. The 'low-moderate risk' group may fast, provided their medications and clinical conditions allow. The 'high' or 'very high risk' groups should not fast and may consider safe alternatives such as non-consecutive fasts or fasting shorter days, for example, during winter. All patients who are fasting should be educated before Ramadan on their risk and management (including the risk of dehydration, fluid overload and terminating the fast if they become unwell) and reviewed after Ramadan to reassess their risk status and condition. Further studies to clarify the benefits and risks of fasting on the cardiovascular system in patients with different cardiovascular conditions should help refine these recommendations.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Akhtar AM, Ghouri N, Chahal CAA, et al. Ramadan fasting: recommendations for patients with cardiovascular disease. Heart. 2021. PMID: 33990414. doi:10.1136/heartjnl-2021-319273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。